Skip to Content

UK Edition. Click here for US version.


Active substance(s): BRIMONIDINE TARTRATE

PDF options:  View Fullscreen   Download PDF

PDF Transcript

Insert - Alphagan® - Ireland - MoH Submission

ADR Reporting The Medicines Authority Post-Licensing Directorate 203 Level 3,
Rue D’Argens GŻR-1368 Gżira

By reporting side effects you can help provide more information on the safety of this



Keep out of the reach and sight of children.
Do not store above 25°C.
Do not use the bottle if the tamper-proof seal on the bottle is broken before first use.
Do not use Alphagan after the expiry date which is stated on the bottle label and
the carton after EXP:. The expiry date refers to the last day of that month.
Throw the bottle away 28 days after opening, even if there is solution

Medicines should not be disposed of via wastewater or household waste. Ask your
pharmacist how to dispose of medicines no longer required. These measures will
help to protect the environment.


What Alphagan contains
• The active substance is brimonidine tartrate. One ml solution contains 2.0 mg
brimonidine tartrate, equivalent to 1.3 mg of brimonidine.
• The other ingredients are benzalkonium chloride as a preservative, poly(vinyl
alcohol), sodium chloride, sodium citrate, citric acid monohydrate, purified water
and sodium hydroxide or hydrochloric acid for pH-adjustment.
What Alphagan looks like and contents of the pack
Alphagan is a clear, greenish-yellow to light greenish-yellow eye drop solution in
a plastic bottle. Each bottle contains either 2.5 ml, 5 ml or 10 ml of the medicine.
Alphagan is available in packs of 1, 3 or 6 bottles.
Not all pack sizes may be marketed.
Marketing Authorisation Holder and Manufacturer

Marketing Authorisation Holder
Allergan Ltd, 1st Floor Marlow International, The Parkway, Marlow, Bucks, SL7 1YL, UK
Allergan Pharmaceuticals Ireland, Castlebar Road, Westport, Co. Mayo, Ireland
Allergan Pharmaceuticals Ireland, Castlebar Road, Westport, Co. Mayo, Ireland

This medicinal product is authorised in the Member States of the EEA under the
following names:

Alphagan 0,2% Augentropfen

Belgium, Finland, France, Greece,
Iceland, Luxembourg, Norway, Portugal



Denmark, Ireland, Italy, Netherlands,
Spain, Sweden, United Kingdom

Alphagan 0,2% m/V (2 mg/ml) Augentropfen

Read all of this leaflet carefully before you start using this medicine.
-- Keep this leaflet. You may need to read it again.
-- If you have any further questions, ask your doctor or pharmacist.
-- This medicine has been prescribed for you. Do not pass it on to others. It may
harm them, even if their symptoms are the same as yours.
-- If any of the side effects gets serious, or if you notice any side effects not listed in
this leaflet, please tell your doctor or pharmacist.
In this leaflet:

What ALPHAGAN is and what it is used for
Before you use ALPHAGAN
How to use ALPHAGAN
Possible side effects
How to store ALPHAGAN
Further information


Alphagan is used to reduce pressure within the eye.
It can be used either alone, when beta-blocker eye drops are contraindicated, or
with another eye drop, when a single medicine is not enough to lower the increased
pressure in the eye, in the treatment of open angle glaucoma or ocular hypertension.
The active ingredient in Alphagan is brimonidine tartrate, which works by reducing
pressure within the eyeball.


Do not use Alphagan
• If you are allergic (hypersensitive) to brimonidine tartrate or any of the other
ingredients of Alphagan.
• If you are taking monoamine oxidase (MAO) inhibitors or certain antidepressants.
You must inform your doctor if you are taking any antidepressant drug.
• If you are breast-feeding.
• In infants/babies (from birth until 2 years).
Take special care with Alphagan
Before you take this medicine, tell your doctor:
• If you suffer or have suffered from depression, reduced mental capacity, reduced
blood supply to the brain, heart problems, a disturbed blood supply of the limbs
or a blood pressure disorder.
• If you have or have had in the past kidney or liver problems.
• If being given to a child between the age of 2 and 12 years because Alphagan is
not recommended for use in this age group.

Alphagan 0.2%

This leaflet was last revised in 11/2014.

Further information about glaucoma is available from:
International Glaucoma Association (IGA)
Tel: +44 (0) 1233 64 81 70
Fax: +44 (0) 1233 64 81 79

Using other medicines
Please tell your doctor or pharmacist if you are taking or have recently taken any
other medicines, including medicines obtained without a prescription.

(The IGA is an organisation which helps glaucoma patients and their relatives, and is
not associated with Allergan.)


Artwork created at 100%
Drop all keylines and notes before printing
Part Number: 72130MD310F
Drawing Number: 0106901

0.2% w/v (2 mg/ml)
eye drops, solution
Brimonidine tartrate

Tell your doctor if you are taking any of the following medicines:
• pain killers, sedatives, opiates, barbiturates or are regularly consuming alcohol
• anaesthetics
• to treat a heart condition or to lower blood pressure
• that can affect the metabolism like chlorpromazine, methylphenidate and
• which work on the same receptor as Alphagan, for example isoprenaline and
• monoamine oxidase (MAO) inhibitors and other antidepressants
• medicines for any condition, even if unrelated to your eye condition
• or if the dose of any of your current medicines is changed.
These could affect your treatment with Alphagan.
Pregnancy and breast-feeding
Ask your doctor or pharmacist for advice before taking any medicine. Tell your doctor
if you are pregnant or planning to become pregnant.
Alphagan should not be used while breast-feeding.


Like all medicines, Alphagan can cause side effects, although not everybody gets
them. The chance of having a side effect is described by the following categories:

Driving and using machines
• Alphagan may cause blurred or abnormal
vision. This effect may seem worse at night
or in reduced lighting.
• Alphagan may also cause drowsiness or
tiredness in some patients.
• If you experience any of these symptoms,
do not drive or use machinery until the
symptoms are cleared.
Important information about some of the ingredients of ALPHAGAN
A preservative in Alphagan (benzalkonium chloride) may cause eye irritation and
is also known to discolour soft contact lenses. Therefore, avoid contact with soft
lenses. If you wear soft contact lenses take them out before using these eye drops
and then wait 15 minutes after using Alphagan before inserting your lenses.


Always use Alphagan exactly as your doctor has told you. You should check with
your doctor or pharmacist if you are not sure.
The usual dose is one drop twice daily in the affected eye(s), approximately 12 hours apart.
Children under 12 years
Alphagan must not be used for infants below 2 years of age.
Alphagan is not recommended for use in children (from 2 years until 12 years).
Instructions for use
Alphagan comes as eye drops. Always wash your hands before applying eye drops.
Your prescription label tells you how many drops to use at each dose. If you use
Alphagan with another eye drop, wait 5-15 minutes before applying the second
eye drop.
Apply your eye drops in the following way:


Tilt your head back and look at the ceiling.
Gently pull the lower eyelid down until there is a small pocket.
Squeeze the upturned dropper bottle to release a drop into your eye.
Whilst keeping the affected eye closed, press your finger against the corner of
the closed eye (the side where the eye meets the nose) and hold for 1 minute.

Avoid touching the dropper tip against your eye or anything else.
Replace and tighten the cap straight after use.
If you use more Alphagan than you should

In adults who were instilling more drops than prescribed, the side effects reported
were those already known to occur with Alphagan.
Adults who accidentally swallowed Alphagan experienced decrease in blood
pressure, which in some patients was followed by the increase in blood pressure.
Serious side effects were reported in children who accidentally swallowed Alphagan.
Signs included sleepiness, floppiness, low body temperature, paleness and
breathing difficulties. Should this happen, contact your doctor immediately.
Adults and Children
If Alphagan has been accidentally swallowed or if you have used more Alphagan
than you should, please contact your doctor immediately.
If you forget to use Alphagan
If you forget to take a dose, apply it as soon as you remember. If, however, it is
almost time for your next dose, you should omit the missed dose altogether and then
follow your normal routine.
If you stop using Alphagan
To be effective Alphagan must be used every day. Do not stop using Alphagan until
your doctor tells you to.
If you have any further questions on the use of this product, ask your doctor or

Very common
Very rare

Occurs in more than 1 out of 10 patients
Occurs in fewer than 1 out of 10 patients
Occurs in fewer than 1 out of 100 patients
Occurs in fewer than 1 out of 1,000 patients
Occurs in fewer than 1 out of 10,000 patients

The following eye side effects may be seen with Alphagan.
Affecting the eye

Very common:
• Irritation of the eye (eye redness, burning, stinging, a feeling of something in
the eye, itching, follicles or white spots on the see-through layer which covers
the surface of the eye)
• Blurred vision
• An allergic reaction in the eye

• Local irritation (inflammation and swelling of the eyelid, swelling of the see-through
layer which covers the surface of the eye, sticky eyes, pain and tearing)
• Sensitivity to light
• Erosion on the surface of the eye and staining
• Eye dryness
• Whitening of the see-through layer which covers the surface of the eye
• Abnormal vision
• Inflammation of the see-through layer which covers the surface of the eye

Very rare:
• Inflammation within the eye
• Reduction in pupil size

Side effects where the occurrence is unknown:
• Itching of eyelids

Affecting the body

Very common:
• Headache
• Dry mouth
• Tiredness/drowsiness

• Dizziness
• Cold-like symptoms
• Symptoms involving the stomach and digestion
• Abnormal taste
• General weakness

• Depression
• Palpitations or changes in heart rate
• Dry nose
• General allergic reactions

• Shortness of breath

Very rare:
• Sleeplessness
• Fainting
• High blood pressure
• Low blood pressure

Side effects where the occurrence is unknown:
• Skin reactions including redness, face swelling, itching, rash and widening of
blood vessels

Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any
possible side effects not listed in this leaflet. You can also report side effects directly via:

United Kingdom
Yellow Card Scheme
HPRA Pharmacovigilance
Earlsfort Terrace
IRL - Dublin 2
Tel: +353 1 6764971
Fax: +353 1 6762517

+ Expand Transcript

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.